Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$427M |
| 2 |
Roku
ROKU
|
+$393M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$345M |
| 4 |
AT&T
T
|
+$317M |
| 5 |
Qualcomm
QCOM
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.41B |
| 2 |
Pinduoduo
PDD
|
+$755M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$558M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.86% |
| 2 | Technology | 17.76% |
| 3 | Communication Services | 11.48% |
| 4 | Consumer Discretionary | 10.7% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.24B
| $1.32M | ﹤0.01% |
17,100
-70,700
| -81% | -$5.62M |
|
2477
ResMed
RMD
$32.6B
| $1.32M | ﹤0.01% |
6,887
+3,680
| +115% | +$738K |
|
2478
Genprex
GNPX
$2.22M
| $1.32M | ﹤0.01% |
+7
| New | +$1.54M |
|
2479
iShares International Treasury Bond ETF
IGOV
$1.53B
| $1.32M | ﹤0.01% |
25,400
+5,606
| +28% | +$302K |
|
|
EFC
2480
Ellington Financial
EFC
$1.77B
| $1.32M | ﹤0.01% |
82,300
-31,500
| -28% | -$497K |
|
|
IFLN
2481
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
| $1.32M | ﹤0.01% |
68,066
-68,834
| -50% | -$1.33M |
|
|
AC
2482
DELISTED
Associated Capital Group
AC
| $1.31M | ﹤0.01% |
36,575
-2,925
| -7% | -$104K |
|
2483
Precision BioSciences
DTIL
$204M
| $1.31M | ﹤0.01% |
4,215
+2,977
| +240% | +$1.04M |
|
2484
Astrana Health
ASTH
$2B
| $1.3M | ﹤0.01% |
47,900
-8,500
| -15% | -$204K |
|
|
TBI
2485
Trueblue
TBI
$315M
| $1.29M | ﹤0.01% |
58,800
+16,600
| +39% | +$340K |
|
|
THER
2486
DELISTED
THERATECHNOLOGIES INC COM
THER
| $1.29M | ﹤0.01% |
335,000
+204,894
| +157% | +$792K |
|
2487
Nordson
NDSN
$17.2B
| $1.29M | ﹤0.01% |
+6,514
| New | +$1.27M |
|
|
NVEE
2488
DELISTED
NV5 Global
NVEE
| $1.29M | ﹤0.01% |
+53,580
| New | +$1.28M |
|
2489
Cartesian Therapeutics
RNAC
$266M
| $1.29M | ﹤0.01% |
9,483
-22,891
| -71% | -$2.84M |
|
2490
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.04B
| $1.28M | ﹤0.01% |
35,500
-400
| -1% | -$14.2K |
|
|
CATC
2491
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.28M | ﹤0.01% |
15,241
-6,332
| -29% | -$496K |
|
2492
TAT Technologies
TATT
$532M
| $1.28M | ﹤0.01% |
249,600
+7,300
| +3% | +$42K |
|
2493
Minerva Neurosciences
NERV
$213M
| $1.28M | ﹤0.01% |
54,888
-30,893
| -36% | -$772K |
|
2494
CNA Financial
CNA
$13.9B
| $1.28M | ﹤0.01% |
28,699
-279,200
| -91% | -$11.9M |
|
2495
Hennessy Advisors
HNNA
$78.6M
| $1.28M | ﹤0.01% |
148,336
+18,507
| +14% | +$162K |
|
2496
Twin Disc
TWIN
$352M
| $1.28M | ﹤0.01% |
133,593
-62,400
| -32% | -$554K |
|
|
STR
2497
DELISTED
Sitio Royalties
STR
| $1.27M | ﹤0.01% |
70,975
+18,249
| +35% | +$290K |
|
2498
iShares Core MSCI Europe ETF
IEUR
$9.14B
| $1.27M | ﹤0.01% |
23,600
+16,200
| +219% | +$859K |
|
|
SCPH
2499
DELISTED
scPharmaceuticals
SCPH
| $1.27M | ﹤0.01% |
191,386
-55,700
| -23% | -$382K |
|
|
CVSA
2500
Covista Inc
CVSA
$4.47B
| $1.27M | ﹤0.01% |
+32,100
| New | +$1.25M |
|
Similar funds
Jim Simons's Q1 2021 Portfolio in Review
As of Q1 2021, Jim Simons held 3,937 positions worth $80.4B, down 13% from $92.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons withdrew a net $16B in Q1 2021, closing 676 positions and reducing 1,579 holdings. Its most notable exit was Micron Technology, an estimated $252M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Jim Simons opened a new position in Paramount Global Class B worth $255M.
- Jim Simons's largest Q1 2021 buy was Paramount Global Class B: 5,644,997 shares worth $255M.
- Jim Simons added most to Tesla in Q1 2021, an estimated $427M increase.
- Jim Simons's biggest Q1 2021 reduction was Baidu, cutting an estimated $1.41B.
- Jim Simons fully exited Micron Technology in Q1 2021, selling an estimated $252M.
- Jim Simons's ten largest holdings make up 10% of its $80.4B portfolio in Q1 2021.
- Jim Simons opened 591 new positions and closed 676 in Q1 2021.
- Jim Simons's portfolio value fell 13% quarter-over-quarter to $80.4B.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.